Replimune Group (NASDAQ:REPL – Get Free Report) issued its earnings results on Thursday. The company reported ($0.77) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.89) by $0.12, Briefing.com reports. Replimune Group Stock Up 0.9 % Shares of REPL traded up $0.07 during trading hours on Friday, hitting $7.79. The stock had […]
Integral Health Asset Management LLC lifted its stake in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 79.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 395,000 shares of the company’s stock after acquiring an additional 175,000 shares during the […]
Replimune Group (NASDAQ:REPL) Price Target Lowered to $50 00 at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Replimune Group (NASDAQ:REPL – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.75) EPS for the quarter, topping analysts’ consensus estimates of ($0.80) by $0.05, Briefing.com reports. During the same period in the prior year, the firm earned ($0.78) earnings per share. Replimune Group Stock Up 2.8 % REPL stock […]
Emerald Advisers LLC cut its stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 18.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 963,041 shares of the company’s stock after selling 223,000 shares during the period. Emerald Advisers LLC […]